Carolinas Wealth Consulting’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,885
Closed -$98K 1045
2024
Q1
$98K Hold
5,885
0.02% 256
2023
Q4
$88K Hold
5,885
0.02% 253
2023
Q3
$82.3K Hold
5,885
0.02% 239
2023
Q2
$89.7K Hold
5,885
0.02% 275
2023
Q1
$89.1K Hold
5,885
0.02% 279
2022
Q4
$81.6K Hold
5,885
0.02% 292
2022
Q3
$80K Hold
5,885
0.02% 272
2022
Q2
$86K Buy
5,885
+1,110
+23% +$17.1K 0.02% 266
2022
Q1
$79K Buy
+4,775
New +$83.9K 0.02% 280

Other funds holding BCAT

Carolinas Wealth Consulting's BCAT Position: Q2 2024 in Review

Carolinas Wealth Consulting sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2024, closing a stake of 5,885 shares — an estimated $98K sold.

Carolinas Wealth Consulting first reported a position in BCAT in Q1 2022 and held it in 9 quarters. The position peaked at $98K in Q1 2024. 86 funds tracked by Wall St. Rank hold BCAT as of Q2 2024.

  • Carolinas Wealth Consulting reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2024 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 5,885 BlackRock Capital Allocation Term Trust shares in Q2 2024, an estimated $98K.
  • Carolinas Wealth Consulting first reported a position in BlackRock Capital Allocation Term Trust in Q1 2022 and held it in 9 quarters.
  • Carolinas Wealth Consulting's BlackRock Capital Allocation Term Trust position peaked at $98K in Q1 2024.
  • 86 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2024.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2024, filed 12 Aug 2024.